Prevalence and risk factors for hearing loss in high-risk neonates in Germany.
Hearing loss
High-risk neonates
Newborn hearing screening
Risk factors
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
14
10
2018
revised:
11
02
2019
accepted:
06
05
2019
pubmed:
11
5
2019
medline:
2
10
2020
entrez:
11
5
2019
Statut:
ppublish
Résumé
Hearing loss in infants is often diagnosed late, despite universal screening programmes. Risk factors of hearing impairment in high-risk neonates, identified from population-based studies, can inform policy around targeted screening. Our aim was to determine the prevalence and the risk factors of hearing loss in a high-risk neonatal population. This was a retrospective cohort study of neonates hospitalised at the University Hospital Cologne, Germany from January 2009 to December 2014 and were part of the newborn hearing screening programme. Multivariable regression analyses using the lasso approach was performed. Data were available for 4512 (43% female) neonates with a mean gestational age at birth of 35.5 weeks. The prevalence of hearing loss was 1.6%, and 42 (0.9%) neonates had permanent hearing loss. Craniofacial anomalies, hyperbilirubinaemia requiring exchange transfusion, oxygen supplementation after 36 weeks of gestation and hydrops fetalis showed associations with permanent hearing loss. Our findings of risk factors for hearing loss were consistent with other studies. However, some commonly demonstrated risk factors such as perinatal infections, meningitis, sepsis and ototoxic drugs did not show significant associations in our cohort. Targeted screening based on risk factors may help early identification of hearing loss in neonates.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1972-1977Informations de copyright
©2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Références
WHO. Newborn and infant hearing screening: current issues and guiding principles for action. Geneva, Switzerland: WHO, 2010.
Ohl C, Dornier L, Czajka C, Chobaut JC, Tavernier L. Newborn hearing screening on infants at risk. Int J Pediatr Otorhinolaryngol 2009; 73: 1691-5.
Matulat P, Fabian S, Kohn A, Spormann-Lagodziski M, Lang-Roth R, Rissmann A, et al. Quality of universal newborn hearing screening results: multicenter analysis of data recorded between 2009 and 2012 in four German states. HNO 2014; 62: 171-9.
American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120: 898-921.
Hille ET, van Straaten HI, Verkerk PH, Dutch NICU Neonatal Hearing Screening Working Group. Prevalence and independent risk factors for hearing loss in NICU infants. Acta Paediatr 2007; 96: 1155-8.
Wang CH, Yang CY, Lien R, Chu SM, Hsu JF, Fu RH, et al. Prevalence and independent risk factors for hearing impairment among very low birth weight infants. Int J Pediatr Otorhinolaryngol 2017; 93: 123-7.
Hosono S, Imura S, Akiyama K, Takigawa I, Ishizeki S, Takeda H. Effect of vibration on auditory organ systems in low-birth weight infants treated with high-frequency oscillatory ventilation: 5 year outcome. Pediatr Int 2001; 43: 16-9.
Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012; 206: 141.e1-8.
Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodol 2005; 67: 301-20.
Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B Stat Methodol 1996; 58: 267-88.
Van Kerschaver E, Boudewyns AN, Declau F, Van de Heyning PH, Wuyts FL. Socio-demographic determinants of hearing impairment studied in 103,835 term babies. Eur J Public Health 2013; 23: 55-60.
Finckh-Kramer U, Spormann-Lagodzinski M, Gross M. German registry for hearing loss in children: results after 4 years. Int J Pediatr Otorhinolaryngol 2000; 56: 113-27.
Meyer C, Witte J, Hildmann A, Hennecke KH, Schunck KU, Maul K, et al. Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics 1999; 104(4 Pt 1): 900-4.
Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005; 94: 59-64.
Mossey PA, Catilla EE. Global registry and database on craniofacial anomalies: report of a WHO registry meeting on craniofacial anomalies. 2003.
Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol 2015; 42: 29-45, vii-viii.
Atkinson LR, Escobar GJ, Takayama JI, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline? Pediatrics 2003; 111(5 Pt 1): e555-61.
Thornberg E, Thiringer K, Odeback A, Milsom I. Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatr 1995; 84: 927-32.
Ratanasiri T, Komwilaisak R, Sittivech A, Kleebkeaw P, Seejorn K. Incidence, causes and pregnancy outcomes of hydrops fetalis at Srinagarind Hospital, 1996-2005: a 10-year review. J Med Assoc Thai 2009; 92: 594-9.
Vos B, Senterre C, Lagasse R, Leveque A. Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors. BMC Pediatr 2015; 15: 160.
Wickremasinghe AC, Risley RJ, Kuzniewicz MW, Wu YW, Walsh EM, Wi S, et al. Risk of sensorineural hearing loss and bilirubin exchange transfusion thresholds. Pediatrics 2015; 136: 505-12.
Wroblewska-Seniuk K, Greczka G, Dabrowski P, Szyfter W, Mazela J. The results of newborn hearing screening by means of transient otoacoustic emissions - has anything changed over 10 years? Int J Pediatr Otorhinolaryngol 2017; 96: 4-10.
Rastogi S, Mikhael M, Filipov P, Rastogi D. Effects of ventilation on hearing loss in preterm neonates: nasal continuous positive pressure does not increase the risk of hearing loss in ventilated neonates. Int J Pediatr Otorhinolaryngol 2013; 77: 402-6.
Picciotti PM, Agostino SE, Di Nardo W, Scarano E. Scanning electron microscopy of cochlea in new-born rats exposed to hyperbaric oxygen: preliminary report. Acta Otorhinolaryngol Ital 2005; 25: 267-70.
Coulston J, Balaratnam N. Irreversible sensorineural hearing loss due to clarithromycin. Postgrad Med J 2005; 81: 58-9.
Segar JL. Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol 2012; 39: 209-20.
Khairy MA, Abuelhamed WA, Ahmed RS, El Fouly HES, Elhawary IM. Hearing loss among high-risk newborns admitted to a tertiary Neonatal Intensive Care Unit. J Matern Fetal Neonatal Med 2018; 31: 1756-1761.
Mannan MA, Choudhury SM, Dey AC, Dey SK, Naher BS, Shahidullah M. Newborn hearing screening: what are we missing? Bangladesh Med Res Counc Bull 2014; 40: 1-5.
Nelson HD, Bougatsos C, Nygren P.Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Rockville (MD). 2008.
Nennstiel-Ratzel U, Brockow I, Söhl K, Zirngibl A, am Zehnhoff-Dinnesen A, Matulat P, et al.Endbericht zur Evaluation des Neugeborenen-Hörscreenings 2011/2012. 2017.